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Abstract
Background: Normative guidelines from the World Health Organization recommend tracking strategic information indicators
among key populations. Monitoring progress in the global response to the HIV epidemic uses indicators put forward by the Joint
United Nations Programme on HIV/AIDS. These include the 90-90-90 targets that require a realignment of surveillance data,
routinely collected program data, and medical record data, which historically have developed separately.
Objective: The aim of this study was to describe current challenges for monitoring HIV-related strategic information indicators
among key populations ((men who have sex with men [MSM], people in prisons and other closed settings, people who inject
drugs, sex workers, and transgender people) and identify future opportunities to enhance the use of surveillance data, programmatic
data, and medical record data to describe the HIV epidemic among key populations and measure the coverage of HIV prevention,
care, and treatment programs.
Methods: To provide a historical perspective, we completed a scoping review of the expansion of HIV surveillance among key
populations over the past three decades. To describe current efforts, we conducted a review of the literature to identify published
examples of SI indicator estimates among key populations. To describe anticipated challenges and future opportunities to improve
measurement of strategic information indicators, particularly from routine program and health data, we consulted participants of
the Third Global HIV Surveillance Meeting in Bangkok, where the 2015 World Health Organization strategic information
guidelines were launched.
Results: There remains suboptimal alignment of surveillance and programmatic data, as well as routinely collected medical
records to facilitate the reporting of the 90-90-90 indicators for HIV among key populations. Studies (n=3) with estimates of all
three 90-90-90 indicators rely on cross-sectional survey data. Programmatic data and medical record data continue to be insufficiently
robust to provide estimates of the 90-90-90 targets for key populations.
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Conclusions: Current reliance on more active data collection processes, including key population-specific surveys, remains
warranted until the quality and validity of passively collected routine program and medical record data for key populations is
optimized.
(JMIR Public Health Surveill 2018;4(2):e28)   doi:10.2196/publichealth.8042
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Introduction
New Vision for Strategic Information
The 2015 World Health Organization (WHO) guidelines for
HIV-related strategic information (SI) [1] present a consolidated
framework across the full information cycle for HIV (Figure
1), from traditional surveillance indicators, such as HIV
prevalence, incidence, and geographic distribution, to indicators
monitoring program response, target setting, coverage, and
effectiveness. To provide an integrated assessment of progress
along one HIV result chain, the guidelines recommend aligning
data elements from multiple sources, including health facilities,
HIV prevention and treatment programs, and population-based
surveys, and disaggregating indicators by population groups.
See Figure 1.
Disaggregation of HIV surveillance indicators [2] for the five
key populations recognized by WHO (men who have sex with
men [MSM], people in prisons and other closed settings, people
who inject drugs, sex workers, and transgender people [3]) is
an important objective, given that key populations and their
sexual partners accounted for about 45% of all new HIV
infections in 2015 [4]. Additionally, the role of key populations
within the HIV epidemics in countries with generalized
epidemics may be greater than previously thought [5,6]. Stigma
and social and economic vulnerabilities pose sustained
challenges for the uptake of HIV prevention and treatment
services among key populations, making it especially important
to document gaps in program coverage for these populations
[7,8].
Operational Challenges for Indicators for Key
Populations
The guidelines recommend estimating key population-specific
indicators drawn from multiple data sources; however, the
operational challenges of this are significant. First, there are
often no standardized definitions for key populations and
subgroups. Transgender women are not consistently classified
separately from MSM; women who exchange sex for goods or
services or work part-time may or may not be included as sex
workers; and MSM are often considered one group, despite the
significant diversity of HIV acquisition and transmission risks
among MSM [9,10]. Eligibility criteria for participation in
surveys are generally more restrictive than for programs. Sex
worker surveys may restrict participation to women aged 18
years and older who report commercial sex in the past 3 months,
whereas programs do not generally screen out part-time sex
workers or adolescents who exchange sex for goods or services.
An assessment by the Joint United Nations Programme on
HIV/AIDS (UNAIDS) and the Global Fund to Fight AIDS,
Tuberculosis, and Malaria of the availability and quality of
subnational data on sexually transmitted infection (STI) or HIV
prevalence, behaviors, and coverage of HIV testing and size
estimates for key populations in low- and middle-income
countries between 2001 and 2015 found wide variation in the
definition of key populations and few examples where
definitions were sufficiently consistent to allow trend analysis
[11].
Second, as progress is made in reaching the most accessible
members of key populations, the HIV epidemic will reach a
phase [12] where transmission becomes more concentrated in
subgroups that are more hidden, mobile, and harder to reach.
Tracking the epidemic among these dynamic subgroups and
monitoring program coverage and outreach to them will require
an SI system that is flexible, able to identify the emergence of
subgroups, and align surveillance trends with program coverage
trends. Bio-behavioral surveys such as those recommended by
the UNAIDS and WHO Working Group on Global HIV/AIDS
and STI Surveillance, currently operate on a 2- to 4-year cycle
and, thus, will be challenged to provide flexibility and timely
responses to program needs for information. If the coverage
area for the survey does not match the catchment area for the
specific programs or clinic services, the value of the survey data
for immediate local use may be further obscured.
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Figure 1. Strategic information cycle.
Third, beyond the challenges of aligning population definitions,
identifying subgroups, and geographic reach, there is the
challenge of reconciling the different sources of bias in and
across survey methods, program monitoring systems, and routine
medical record data systems. Different survey and population
size estimation methods can result in different HIV prevalence
and size estimates for the same population in the same location
[13]. Methods such as programmatic mapping rely on
information directly obtained from members of the community
of interest, as well as indirect information obtained about key
populations indirectly from other people who are engaged with
the community. This mixed-methods approach may provide
information that differs from surveys of population members
only. Venue-based estimates are not often adjusted to include
individuals who do not attend venues. Additional biases can
emerge when sampling does not take mobility of the population
into account, or if stigma, fear, or safety concerns limit
engagement with key populations at public venues. Estimates
from respondent-driven sampling (RDS) may be biased if there
is significant clustering by subgroup [14] or geographic area
[15]. As more members of key populations are tested and linked
to care, it is possible that those who already know they are living
with HIV will disproportionately refuse participation in surveys,
further biasing the prevalence estimates. Tracking the epidemic
and assessing program coverage among persons who move in,
out, or across one or more key populations over time [16,17] is
challenging but important to monitor coverage among those
who may be least likely to be reached. For example, a
transgender woman who sells sex and injects drugs may be less
likely to access harm reduction services where stigma against
transgender women may exist.
Finally, although estimation of the number and percent of new
HIV infections is one of the 10 global indicators recommended
in the new guidelines, there are methodological and operational
challenges of validly measuring incidence among key
populations [3]. The most epidemiologically rigorous approach
to measure incidence, a prospective cohort study, requires
significant resources to develop and maintain, so, it is rarely
feasible and can be difficult to interpret given limited
generalizability or if the cohort is mobile with significant loss
to follow-up [18]. Measuring the social, political, and economic
drivers [19,20] of HIV incidence among key populations is also
challenging, but efforts to prevent HIV transmission will be
limited if we fail to acknowledge the role of these drivers or the
structural interventions [20] designed to address them.
We reviewed the published history of HIV surveillance among
key populations to put the current challenges into context;
identify future opportunities to enhance the use of surveillance
data, programmatic data, and medical record data; describe the
HIV epidemic among key populations; and measure the coverage
of HIV prevention, care, and treatment programs.
Methods
We described the historical expansion of HIV surveillance using
published guidelines from WHO and UNAIDS, early
surveillance reports identified using MEDLINE, and coauthor
recollection.
We described the current salient features of four sources of SI:
national household surveys, targeted bio-behavioral surveys,
medical record data, and program data sources. We included
known strengths, weaknesses, and opportunities for improved
use of these data sources, with a focus on estimating elements
of the treatment and prevention cascades [21,22].
We also review published estimates of 90-90-90 indicators based
on these data sources to identify the availability of cascade
estimates for key populations and the extent to which they drew
on program, survey, and treatment databases. We conducted a
title or abstract search in MEDLINE using the terms: HIV AND
[HIV Testing OR population size estimate OR Viral Suppression
OR antiretroviral therapy] AND [key populations OR MSM
OR sex workers OR injection drug use OR prison OR
transgender OR concentrated epidemic] AND [program data
OR surveillance data OR routine data OR medical records]. We
included manuscripts based on two criteria: (1) it reported any
elements of the 90-90-90 HIV treatment cascade (population
size, the proportion of the population who know their HIV status,
the proportion of the population with HIV that is receiving
antiretroviral therapy [ART], and the proportion of the
population that is achieving viral suppression) for key
populations from low- or middle-income countries and (2) it
described strengths or weaknesses of data sources, or issues of
aligning data from different sources. For studies where inclusion
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criteria could not be determined based solely on the abstract,
we searched the full article.
Results
History of Surveillance Among Key Populations
Surveillance of the HIV pandemic has evolved over the past
three decades, but from the earliest days it has included
information about key populations. Early clinical case reports
of patients with AIDS in Haiti in 1983 [23], in the Democratic
Republic of Congo (Zaire) in 1984 [24], and in Rwanda 1984
[25], focused on clinical manifestations and immunological
findings but also noted the presence or absence of behavioral
risk, including homosexuality, injecting drug use, and
prostitution. In 1985, a human T-cell lymphocyte virus
prevalence study in Thailand [26] identified specific high-risk
groups as male, homosexual sex workers; thalassemia patients;
female sex workers; parenteral drug users; male, venereal disease
patients; and blood donors. In 1986, a cohort of gay men in a
hepatitis B study was assessed for evidence of AIDS [27]. A
Lancet report from Rwanda in 1985 conveyed the first clear
recommendation to focus on the risk posed by sex work [28].
The report concluded that “Since prostitution is widespread in
Central African cities...infection may exist in a large, unconfined
group of the general heterosexual population...Among
heterosexual populations, prostitutes and probably their male
customers should be regarded as high-risk groups.”
Subsequently, guidance surrounding data collection and
monitoring for high-risk subgroups started to appear. In 1985,
a WHO Coordinating Center Report [29] noted that “An
important aspect of WHO activities...will be the collection of
data on the incidence of the disease or its causative virus by
Member States and the WHO Collaborating Centers...Wherever
possible, information on the gender, age, recognized risk factor
(if any), and major clinical features should also be provided.”
In 1989, the WHO unlinked anonymous testing (UAT)
guidelines addressed the ethics of compulsory HIV testing by
stating that compulsory testing is unethical and that UAT can
only occur when blood was already being taken for another
purpose [30]: Information, such as sex and exposure category
(if known), may accompany the unlinked anonymous specimen,
but the possibility of indirectly identifying people infected with
HIV must be eliminated by ensuring that this information is not
too discriminating, for example, an age group should be used
rather than specific age in years [31]. Despite these guidelines,
there is some evidence that sex workers have been subjected to
compulsory testing [32,33], at least occasionally since the early
years of the HIV epidemic, raising issues of security and
confidentiality for key populations.
In 1999, WHO published a comprehensive guide outlining the
specific data elements required for STI case reporting in clinical
settings [34]. Core elements of this guide included diagnosis,
reporting site, date of visit, gender, age group, age, or date of
birth. Optional data elements included residence, low education
or socioeconomic status, clinical syndrome, anatomic site of
infection, date of symptom onset, risk behaviors, pregnancy,
history of STI, and treatment. Suggested indicators of risk
behavior included the number of sex partners in the past 90 days
(or 12 months), whether there were any new sex partners in the
past 90 days, the gender of sex partners in the past 12 months
(or their sexual orientation), condom use during the last sexual
intercourse, drug use in the past 12 months, and giving or
receiving money or drugs for sex in the past 12 months.
In 2000, WHO published guidelines for second generation
surveillance [35], marking the first description of the strategy
to conduct surveillance among antenatal clients in countries
with generalized epidemics and among high-risk groups
(including sex workers and MSM) among countries with
concentrated and low-level epidemics. Second generation
surveillance expanded the objectives of surveillance beyond
HIV prevalence to include behavioral surveillance and AIDS
case reporting. Population-specific questionnaire modules and
indicators were developed.
In 2013, these guidelines were updated to incorporate the
experiences of countries implementing second generation
surveillance over the past 10 years and to incorporate changes
in survey methods and laboratory diagnostics [36]. Although
guidelines note differing objectives for surveillance (to track
how the epidemic in a country is changing) and monitoring and
evaluation (to track how effectively programs are responding
to the epidemic and whether the outcomes and outputs
correspond to the activities planned), the guidelines
recommended that the systems be designed to be
complementary. Surveillance and survey outcome and impact
data should be used to assess the national program response.
Program data should provide inputs, outputs, and outcomes to
the national monitoring and evaluation system.
In response to each set of guidelines, surveys and surveillance
systems were dynamically changed, though the implementation
varied by country, region, epidemic profile, and study objective.
Currently, many countries have yet to achieve the
recommendations from 2103 to align program and surveillance
data to describe the HIV epidemic and evaluate the response.
Alignment with health record data is a further challenge.
Surveillance activities are often implemented with little regard
for clinical programs, partly because HIV status and ART were
considered too confidential to ask about in surveys. Clinical
data can be challenging to triangulate with survey data because
definitions of geography or reference period and population do
not necessarily align. The current recommendation to estimate
the HIV treatment cascade represents a paradigm shift in
surveillance and program monitoring because valid estimates
of cascade indicators for a district require alignment of
definitions, geography, and reference period across survey,
program, and treatment databases.
Data From Bio-Behavioral Surveys and Programmatic
Mapping
Bio-behavioral surveys of key populations have been the
backbone of HIV surveillance for key populations over the past
15 years, particularly for HIV prevalence estimates and more
recently for size estimates. They provide probability surveys
that facilitate representative estimates. Survey data are used for
reporting country-specific indicators to UNAIDS; for use in
mathematical models, including spectrum estimates; funding
requests; and to guide country-level program reviews. Survey
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instruments have varied by country but commonly include HIV
prevalence, knowledge of HIV transmission routes, sexual
behavior (including condom use), and information to estimate
the size of populations. Knowledge of HIV status, ART status,
and indicators of viral suppression are increasingly included in
survey instruments.
Bio-behavioral surveys have strengths relative to health or
program data to estimate HIV prevalence and the size of the
HIV population. Properly designed and executed bio-behavioral
surveys aim to obtain a probability sample of the population in
contrast to health sector or program data, which have data only
from clients using their services. Surveys can provide an
independent evidence-based assessment of gaps in coverage for
programs and health facilities and identify emerging epidemics
[37,38]. Moreover, validated survey modules on HIV stigma,
the accessibility of health services, violence, and sexual behavior
can provide more in-depth information on sensitive topics and
allow analysis to identify and explore associations between HIV
infection and barriers to accessing prevention and other services
to guide the implementation of programs. Finally, survey data
can provide a profile of those who do not access services, those
who are living with HIV but do not know their HIV status, and
the profile of those initially linked to treatment who report that
they have stopped treatment.
Bio-behavioral surveys, however, have limitations. They are
expensive and time-consuming to implement well, including
effective engagement of stakeholders. Well-conducted surveys
require formative research to guide protocol development, care
in translation and back translation, ethical review by the
appropriate organizations, interviewer training, ongoing
monitoring of data quality, recording of deviations from the
protocol, strategies to ensure data confidentiality and protection
of participants, and strategies to provide participants with test
results and linkage to care if indicated. Because HIV surveillance
often takes place outside the health care system and involves
contracting an outside implementing institution, there must be
careful collaboration between the survey team and those in the
health care system to ensure linkage to care for those who test
positive as part of the survey.
Although survey design may minimize the effects of selection
bias relative to clinical and program data, the effects of
self-presentation bias on the validity of self-reported data may
be considerable [39,40]. The extent to which anal sex,
commercial sex, multiple sexual partnerships, injecting drug
use, unprotected sex (sex without a condom), and lack of
adherence to ART are underreported is unknown. It is likely
that there are shifts in the level of stigma associated with
different behaviors that could affect the interpretation of trends
from surveillance data. For example, the increased availability
of ART has probably led to increased willingness to self-report
HIV infection. Legalization of gay marriage may lead to
increased willingness to report same sex relationships;
crackdowns on MSM may have the reverse effect.
With support from the Global Fund and other donors, countries
are using programmatic mapping to identify where to reach key
populations and to estimate the size of key populations [41].
Programmatic mapping systematically surveys community
informants in a defined geographic area to identify high-risk
venues (also known as hotspots) where key populations can be
reached. In addition to venue-level data, programmatic mapping
can include surveys of a representative sample of venue patrons
and workers and oversampling of key populations [42]. Various
methods exist for programmatic mapping, but all of them share
some strengths and limitations. Strengths for programmatic
mapping include the programmatic value of the maps for
locating sites where key populations can be reached. Size
estimates can be calculated from programmatic mapping and
the estimates used to plan outreach visits by peer educators.
Limitations for programmatic mapping include the limitations
common to other surveys of key populations (as above), as well
as the bias arising from the fact that key populations who do
not visit these venues and will be missed. Other limitations
include the labor-intensive protocol required to ensure that all
sites have been listed and a sufficient sample visited.
There are several opportunities for improving the value of
surveys for program improvement: (1) aligning size estimates
from surveys with program catchment areas; (2) characterizing
those reached by the survey, but missed by programs; (3) using
the Internet for recruitment of survey participants; (4) measuring
the 90-90-90 cascade, including viral suppression; (5)
characterizing subgroups [43], including measures of HIV
incidence, prevalence, and program coverage; (6) measuring
gaps in service delivery; and (7) measuring stigma and its
association with access to and use of services. Use of standard
stigma indicators in surveys, programs, and health sectors could
facilitate improving the quality of care and retention in care and
programs.
For example, providing a cluster of differentiation 4 count at
the time of the survey in Malawi to female sex workers living
with HIV improved the acceptability of HIV testing and
facilitated collecting an additional blood sample to estimate the
proportion of female sex workers who had achieved viral
suppression [44]. Another promising method to identify new
HIV infections among key populations is phylodynamic analyses
[45,46]. Additional strategies to improve the value of surveys
to programs include better engagement of program participants
in the design, implementation, and analysis of survey data,
including contribution of questions related to specific program
elements, as consultants in readiness assessments, as social
mobilizers for recruitment of key populations, and as interpreters
of the data in data-use workshops. In addition, if available,
coverage maps from survey data could be provided to programs
and workshops held to compare indicators from survey with
indicators obtained from programs.
Data From Medical Records
Routinely collected data from medical records and case-based
surveillance systems have recently become a focus of
development to facilitate measuring progress along the cascade.
Where they exist, these data provide the number of persons on
treatment. More sophisticated systems monitor progress along
the cascade at the individual level from the first positive HIV
test to viral suppression. Advocates argue that after HIV
diagnosis, all cascade indicators recommended in the new
Consolidated Guidelines for HIV Surveillance [47] could be
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estimated from case-based surveillance [48]. There is the hope
that as these systems become routine and new technologies
emerge to link data systems, surveillance will improve from the
current cross-sectional approach to an ongoing longitudinal
dynamic system that can more accurately identify those lost to
follow-up.
Challenges in using case-based surveillance and other analyses
of medical records for measuring the cascade among key
populations in resource-constrained countries are evident
already. The system requirements for tracking individual medical
records are not available in many settings. In addition to the
usual issues associated with solving the problem of deduplicating
reports from various sources (eg, interoperability of computer
systems, lack of standardization across providers for reporting,
lack of timeliness in reporting, and lack of a unique identifier,
UID, protocol), a successful case-based surveillance system to
monitor the cascade among key populations would require an
indicator of key population status in the surveillance record.
Inclusion of this indicator is problematic. People may not
self-identify as a member of a key population or want the
indicator on their medical record [49,50]. Current guidelines
do not recommend collecting risk behaviors, that is, key
population status, in medical records if it is not clinically
relevant. Discriminatory behavior can lead to dangerous
situations for members of the populations; in fact, records from
MSM services were recently seized by police in Tanzania.
In addition, other factors pose challenges for the unique
identification of key population members. It is not unusual for
sex workers or gay men to adopt a second identity to hide their
affiliation and present at different clinics based on identity.
Defining membership in a key population may be differently
interpreted across facilities. Membership in a key population
may be quite dynamic, causing problems for interpretation of
the cascade over time. Biometric UIDs such as fingerprint scans
facilitate monitoring at the individual level across data sources
but require careful introduction into the community, technical
support, data protection schemes, ethical review, and ongoing
monitoring.
Due to the stigma associated with being a member of a key
population and the lack of a key population identifier in the
record, it is likely that case-based surveillance systems will
underestimate the size of key populations. Health sector data
will overestimate prevalence if those who are infected are more
likely to seek clinical care (Berkson’s bias) or if clinics with a
higher prevalence of infection among patients are selected for
inclusion in surveillance [51], but could underestimate HIV
prevalence if clinicians are less likely to directly indicate HIV
status in the patient’s medical record (unacceptable disease bias)
[52].
Some promising methods, however, are emerging to improve
linkages between data sources when UIDs are not available, or
an identifier fails to uniquely identify persons. One approach
being piloted in the Dominican Republic is a follow-up survey
of a sample of persons living with HIV in the treatment database
to determine key population membership so that the cascade
can be estimated for this subset of persons in the database.
Improved probabilistic matching strategies based on available
data such as name and birthday may be able to link an
individual’s records across multiple programs when UIDs are
not available. A MEDLINE search in January 2017 of articles
related to probabilistic matching of medical records revealed
68 articles on the topic of probabilistic matching of medical
records for HIV, of which 24 were published in the past 5 years.
Free computer programs to improve deduplication of records
are available, and efforts to evaluate the validity of probabilistic
matching have been conducted [53].
Finally, new analytic tools are being developed to provide
longitudinal measures of the cascade from treatment databases.
These cascades indicate the time spent on the pathway from
first positive HIV test to reaching viral suppression, the last 90
in the treatment cascade. The longitudinal HIV care and
treatment cascade provides an estimate of the person time spent
in each of the compartments of the HIV care continuum [54].
In summary, opportunities exist to leverage service delivery
data to help both individuals and programs address issues for
key populations. There remains much work to improve the
quality of these data; survey data will remain of significant value
for the foreseeable future; active surveillance from targeted
surveys.
Opportunities: Program Data From Key Population
Programs
Since the early 1990s, there has been an acknowledgment that
key populations are at greater risk of acquiring and transmitting
HIV, are less likely to obtain services, and require specific
services. Nongovernmental organizations or special outreach
programs operating from government clinics may provide more
acceptable and tailored services for key populations and may
be more willing to engage key populations in target setting,
advocacy, and addressing barriers to uptake of services. Some
mature programs such as the Avahan sex worker interventions
in India [55] collect longitudinal data on at risk populations,
conduct size estimates, track intervention coverage, and track
HIV prevalence. These programs illustrate that under certain
conditions, with adequate resources, leadership, and stable
funding, mature programs can set targets based on program
data, routinely assess whether targets are met, and only
minimally rely on independent HIV surveillance surveys.
Some of the challenges of using program data revolve around
the variable quality of program data, arising partially from the
broad array of data collection strategies, training, and available
support. The main challenge is that program data is not readily
generalizable to the entire key population (selection bias), as
those who do not visit programs are likely to be different than
those who do. Latecomers to programs differ from the early
volunteers; thus, the maturity of a program will affect the risk
profile of its participants. Even an umbrella program with
multiple service delivery sites that employs a UID may comprise
an unstable cohort if there is significant mobility across
programs and loss to follow-up. Recruitment, attrition, and reach
are often not measured systematically within programs even if
the capacity to do so theoretically exists [53]. New guidelines
for the development, use, and expansion of UIDS for key
populations describe some of the technical and ethical challenges
in linking program data [56].
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National Household Surveys
Probability samples of national household surveys such as the
Demographic and Health Surveys (DHS), the AIDS Indicator
Surveys, and the newer Population-Based HIV Impact
Assessment provide insight into the geographic distribution of
HIV across a country but often fail to provide much insight into
the HIV epidemic among key populations [57]. Members of
key populations may be missed by these surveys for several
reasons: they may not be members of a household if they are
homeless, resident in brothels or guesthouses, or in school; they
may not report [40] sex work, injecting drug use, or
male-with-male sex; and they may be more mobile and less
likely to be available for an in-home interview. One assessment
[58] of the mobility among 1653 female sex workers in
Johannesburg, Rustenburg, and Cape Town, South Africa, found
that 85% were migrants (39% internal and 46% cross-border).
Key populations rarely comprise more than 3% to 8% of the
general population. Financial and logistics constraints usually
preclude interviewing a sufficient number of people in a
household survey to provide an adequate sample of any key
population.
Going forward, however, there may be opportunities for greater
use of national household survey data. A new incidence model
drawing on DHS data estimates the distribution of new
infections in a population for groups, including key populations
[18]. Estimates of the number of sex workers in the Dominican
Republic were also estimated by Bayesian models extrapolating
size estimates from known areas to areas without estimates
using national survey data available in all areas [59]. The
network scale-up method [60,61] has had success with modules
added to some household surveys to estimate the size of key
populations.
Literature Review: Estimates of the 90-90-90
Treatment Cascade Among Key Populations
We identified 14 publications where at least one of the 90-90-90
indicators was estimated. Three provided estimation of each
indicator. The first was an RDS survey among MSM in Moscow,
Russia using RDS [62]; the second estimated 90-90-90 indicators
using mathematical modeling based on inputs from both survey
and programmatic data [63]; and the third was an abstract about
MSM and people who inject drugs) in India [64]. Three studies
only estimated the first 90 [38,65,66] and four only the second
90 [67-70]. Two studies estimated the first and second 90
[71,72], and three survey-based studies estimated all three
indicators of 90-90-90. Among the three studies identified that
included estimates of indicators of 90-90-90 from program data,
two estimated the second 90 and third 90 [73,74], and one
estimated the first 90 and second 90 [75]. In the two studies
identified with estimates based in medical record data, only the
second 90 was estimated from an ART database [76,77].
Discussion
Principal Findings
Current reliance on active data collection processes, including
key population–specific surveillance surveys, is warranted both
to collect specific critical information that cannot be obtained
from service or other program data and to provide a
representative depiction of the HIV epidemic and response.
Elements of the latter may be replaced in the future by passively
collected routine program and medical record data for key
populations. Even in mature programs with years of investment
in reaching and treating key populations, national programs
must leverage data from program data, medical records, and
surveys, as any single source will be insufficient to understand
the HIV epidemic, monitor care, and track progress in prevention
and along the treatment cascade. Bio-behavioral surveys,
although expensive, have proven successful in measuring gaps
in program coverage that are not yet revealed by program or
medical record data. Improving methods to estimate the
treatment cascade from medical records and maintain data
security and patient confidentiality will remain a high priority.
Strategies to gain insight from multiple sources will require
efforts to align geographic catchment areas, definitions,
subgroups, and indicators.
Limitations
There are several limitations of this analysis. Important events
in the history of surveillance were omitted for brevity. An
exhaustive account of the global history of HIV surveillance in
the context of key populations is out of scope; however, an
overview of the progress and challenges were important to
provide some context for the WHO SI guidelines. Important
issues regarding measurement of community engagement, data
quality, data use, mobility, and the effects of interventions on
HIV transmission could not be addressed sufficiently. We did
not describe the many size estimation methods available or
address issues regarding the validity of these size estimation
methods. For transparency, we recommend reporting the
methods used to estimate population size and construct
denominators for 90-90-90 estimates [11].
Although most peer-reviewed studies identified restricted the
analytic sample to highlight a specific key population group,
these analyses often included details about additional high-risk
behaviors, documenting overlap in population membership.
Due to the different risk behaviors of key population subgroups,
the overlap between and among groups, and the variety of legal
restrictions across countries, the opportunities and challenges
related to disaggregating and aligning surveillance data,
programmatic data, and medical record data are considerable.
Currently, complete estimates of indicators for the size of key
population groups and estimates for indicators of the 90-90-90
targets are not generally available. There has been a movement
to increase the use of programmatic data to inform the HIV
epidemic among key populations, although evidence of the
quality and validity of estimates from these data are lacking
[16,78,79,80]. Targeted programs only reach a small fraction
of key populations in most countries. Program data often
overestimate HIV prevalence and underestimate the size of key
populations, possibly because people who are infected are drawn
to programs, whereas others avoid it. Size estimates can also
be overestimated because of incentives at the program level or
individual peer recruiter level if size estimates are larger. Critics
suggest that inflated size estimates lead to inflated program
targets that are impossible to meet.
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Using programmatic data or medical record data for reporting
disaggregated estimates of the 90-90-90 targets is particularly
challenging when high-risk behaviors are overlapping in key
populations, and programs address just one risk behavior. All
individuals at risk of HIV acquisition and transmission may not
identify as a member of the benefactor population [9,10]. There
are programmatic data, particularly from southern and eastern
Africa, showing young MSM disproportionately access
interventions compared with older MSM. The older MSM are
often in relationships with women, and they have heightened
fears that their sexual attraction to men may be inadvertently
disclosed [81,82]. These older men are uncounted, with high
HIV burden, and without targeted services. Collecting robust,
high-quality monitoring, evaluation, and surveillance data from
programs to estimate the size of populations at highest risk is
challenging even when resources are plentiful [55]. Given the
challenges in constructing a denominator from programmatic
and medical record data, care continua and estimates of 90-90-90
from different data sources are biased or fragmented.
UIDs may offer a solution to linking individuals across surveys,
programs, and health care settings if the ethical, logistic, and
technological challenges of implementing UIDs for marginalized
and criminalized populations can be resolved. In many cases,
especially when injection drug use, sex work, or homosexuality
is illegal, providing details about high-risk behaviors and linking
such information to a permanent medical record is a risk that
leaves these already marginalized populations more vulnerable.
WHO’s new case reporting and patient monitoring guidelines
specifically do not include risk behaviors in the patient
monitoring data forms because of the potential for harm to
patients from stigmatized populations [83]. These details are
therefore often underreported [69,76,84]. Other promising
approaches include using the Internet to reach key populations
who engage in online community groups.
In conclusion, we recommend ongoing engagement with key
population communities in the improvement and alignment of
SI indicators across current data sources and exploration of new
sources of data. The goal of SI is to improve the adequacy,
acceptability, safety, and effectiveness of the public health
response to the HIV epidemic among these populations.
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